Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Change in Cash (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Change in Cash readings, the most recent being -$2.2 billion for Q1 2026.

  • On a quarterly basis, Change in Cash fell 435.34% to -$2.2 billion in Q1 2026 year-over-year; TTM through Mar 2026 was -$188.0 million, a 113.64% decrease, with the full-year FY2025 number at $1.6 billion, up 319.38% from a year prior.
  • Change in Cash hit -$2.2 billion in Q1 2026 for GE HealthCare Technologies, down from $486.0 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $1.6 billion in Q3 2024 to a low of -$2.2 billion in Q1 2026.
  • Median Change in Cash over the past 5 years was $59.0 million (2024), compared with a mean of $101.6 million.
  • The widest YoY moves for Change in Cash: up 1926.92% in 2023, down 1720.83% in 2023.
  • GE HealthCare Technologies' Change in Cash stood at $947.0 million in 2022, then crashed by 90.92% to $86.0 million in 2023, then crashed by 889.53% to -$679.0 million in 2024, then skyrocketed by 171.58% to $486.0 million in 2025, then crashed by 558.23% to -$2.2 billion in 2026.
  • The last three reported values for Change in Cash were -$2.2 billion (Q1 2026), $486.0 million (Q4 2025), and $264.0 million (Q3 2025) per Business Quant data.